Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of PF-07220060 with Itraconazole and Probenecid in Healthy Participants
NCT07160738Phase 1Completed
- Sponsor
- Pfizer
- Start
- Sep 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of atirmociclib in breast cancer (2 cohorts), sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration and Area under the plasma concentration versus time curve. Started Sep 2025; status: completed.
02
Drugs
atirmociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07160738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07160738.